Today: 19 July 2026
Browse Category

LSE:BATS.L 21 November 2025 - 16 January 2026

British American Tobacco shares dip after fresh buyback; UBS sees 2026 rebound for BATS stock

British American Tobacco shares dip after fresh buyback; UBS sees 2026 rebound for BATS stock

Shares in British American Tobacco were down 0.5% at 3,990 pence on Friday after the group disclosed another round of share repurchases. The company said it bought 127,066 shares on Jan. 8 at a volume-weighted average price of 4,004.1873 pence and intends to cancel them, leaving 2,178,773,630 shares in issue excluding treasury stock. The stock has traded between 3,982 and 4,016 pence so far, circling the 4,000-pence level.
British American Tobacco (BATS) Stock Update: Buyback Nears Its Finish Line, Dividend Date Looms, and 2026 Guidance Turns Cautious

British American Tobacco (BATS) Stock Update: Buyback Nears Its Finish Line, Dividend Date Looms, and 2026 Guidance Turns Cautious

British American Tobacco p.l.c. is ending 2025 with a familiar cocktail for investors: steady cash returns, aggressive capital allocation, and a tug-of-war between “smoke-free” growth ambitions and regulatory/competitive reality. On 23 December 2025, the company published a fresh “Transaction in Own Shares” update tied to its ongoing buyback programme, a disclosure that lands right as that buyback window reaches its scheduled close. London South East+1
23 December 2025
British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco (BATS.L / BTI) Stock: Today’s Buyback Update, Dividend Dates, and 2026 Outlook (Dec. 17, 2025)

British American Tobacco p.l.c. entered mid-December with its share price near multi-year highs, and the news flow on Wednesday, December 17, 2025 is very “capital allocation meets governance”: the company disclosed another daily share repurchase under its ongoing buyback programme and filed a director declaration under UK listing rules. Meanwhile, investors are still digesting BAT’s early-December FY2025 pre-close trading update, where management reaffirmed its medium-term growth algorithm but signaled that 2026 performance is likely to land at the lower end of its target range—largely because the U.S. vaping market remains distorted by illicit competition and uneven enforcement. Reuters+4Investing.com+4Moneyweb+4
British American Tobacco (BATS.L / BTI) Stock News Today: £1.3bn 2026 Buyback, U.S. Vape Headwinds, Dividends and Analyst Targets (12 December 2025)

British American Tobacco (BATS.L / BTI) Stock News Today: £1.3bn 2026 Buyback, U.S. Vape Headwinds, Dividends and Analyst Targets (12 December 2025)

Meta description: British American Tobacco p.l.c. is in focus on 12 December 2025 after a busy week of updates: continued daily buybacks, a fresh £1.3bn extension for 2026, a pre-close trading update that kept FY2025 guidance intact but flagged FY2026 at the lower end of targets, plus an India divestment tied to debt reduction. Here’s the latest news, forecasts, and market analysis.
Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

Best UK Stocks to Buy Now (10 December 2025): 8 FTSE Shares for Growth, Income & Recovery

Updated 10 December 2025 — With UK inflation easing, interest rates likely past their peak, and a wave of share buybacks supporting valuations, the London market is finally starting to look interesting again for long‑term investors. The FTSE 100 inched higher yesterday as defence names like BAE Systems and Rolls‑Royce offset weakness in British American Tobacco, while investors positioned for potential rate cuts from both the Federal Reserve and the Bank of England in 2026. Reuters+1
British American Tobacco Share Price at 52-Week High: Outlook, Risks and Opportunities Going into 2026

British American Tobacco Share Price at 52-Week High: Outlook, Risks and Opportunities Going into 2026

British American Tobacco p.l.c. is ending 2025 in a place few would have predicted two years ago: the share price is near a 52-week high, analysts are turning more positive, and the company is talking confidently about a return to its long-term growth “algorithm” from 2026. At the same time, regulatory pressure, unlicensed vapes and long-running litigation are still hanging over the group.
Go toTop